Uncertainty persists about the value of palliative radiation, particularly longer regimens, among patients with high-grade gliomas. To address the uncertainty, investigators administered quality of ...

A common misconception persists that palliative care is a “last resort” reserved only for patients at Stage 4 or those nearing the end of life. However, health advocates are shifting this narrative ...

Supportive care should be implemented promptly after patients receive CAR-T cell therapy, but as one expert notes, patients with cancer are often referred for this care too late. Early integration of ...

Using previously taken diagnostic computed tomography (CT) scans in place of CT simulation scans to plan simple palliative radiation treatments can substantially reduce the time some people spend ...

The American Society for Radiation Oncology (ASTRO) recently published an updated clinical guideline that underscores the safety and effectiveness of palliative radiation therapy (RT) for treating ...

MPS Art Therapy presents a lecture on palliative care, a rapidly growing field of medicine that is particularly well-suited for collaboration with art therapists. In this virtual presentation, Ian ...

Outcomes of definitive chemoradiation for squamous cell carcinoma of the anus and the effect of radiation technique on hematologic parameters. Background: In contrast to trials investigating treatment ...

UAB Department of Surgery Assistant Professor Kimberly Kopecky, M.D., MSCI, has been nominated as an official UAB Center of Palliative and Supportive Care (CPSC) Scholar member. Kopecky received her ...

ROCHESTER, N.Y. – Rochester Regional Health is now offering music therapy to patients with serious and complicated health issues to help manage their stress and pain. Kim Best, a music therapist, ...

Tobias Loetscher received funding from the Breakthrough Mental Health Research Foundation for this project. Gregory Crawford has received funding from the NHMRC, the MRFF and Cancer Australia. People ...

This retrospective cohort study used linked registry and claims data on men who were diagnosed with stage IV M0 or stage IV M1b prostate cancer between 2005 and 2009, with associated claims from 2005 ...